ImmuneXcite Receives $5,761,038 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f496685-d9ba-4584-927d-4519115b0559 - Date
12/11/2015 - Company Name
ImmuneXcite - Mailing Address
3 Forbes Road Lexington, MA 02421 USA - Company Description
ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets. - Website
http://www.immunexcite.com - Transaction Type
Venture Equity - Transaction Amount
$5,761,038 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. Total Amount Sold includes conversion of outstanding convertible promissory notes. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. - M&A Terms
- Venture Investor
Undisclosed
